B
LH icon

Barings’s Labcorp LH Stock Holding History

Barings’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-29,633
Closed -$3.65M – 931
2017
Q1 		$3.65M Buy
29,633
+26,513
+850% +$3.14M 0.04% 415
2016
Q4 		$344K Sell
3,120
-4,772
-60% -$530K 0.01% 734
2016
Q3 		$932K Buy
7,892
+5,936
+303% +$699K 0.02% 458
2016
Q2 		$219K Buy
+1,956
New +$211K 0.01% 845
2016
Q1 		– Sell
-1,956
Closed -$208K – 964
2015
Q4 		$208K Sell
1,956
-4,690
-71% -$484K 0.01% 868
2015
Q3 		$619K Sell
6,646
-932
-12% -$96.4K 0.02% 576
2015
Q2 		$789K Hold
7,578
– – 0.02% 580
2015
Q1 		$821K Buy
7,578
+625
+9% +$64.3K 0.02% 561
2014
Q4 		$644K Hold
6,953
– – 0.01% 594
2014
Q3 		$608K Hold
6,953
– – 0.01% 610
2014
Q2 		$612K Buy
6,953
+478
+7% +$41.4K 0.02% 647
2014
Q1 		$546K Hold
6,475
– – 0.02% 640
2013
Q4 		$508K Buy
6,475
+2,269
+54% +$194K 0.02% 609
2013
Q3 		$358K Sell
4,206
-1,629
-28% -$137K 0.02% 711
2013
Q2 		$502K Buy
+5,835
New +$484K 0.02% 598

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Barings's LH Position: Q2 2017 in Review

Barings sold out of Labcorp (LH) in Q2 2017, closing a stake of 29,633 shares — an estimated $3.65M sold.

Barings first reported a position in LH in Q2 2013 and held it in 15 quarters. The position peaked at $3.65M in Q1 2017. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Barings reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
  • Barings sold 29,633 Labcorp shares in Q2 2017, an estimated $3.65M.
  • Barings first reported a position in Labcorp in Q2 2013 and held it in 15 quarters.
  • Barings's Labcorp position peaked at $3.65M in Q1 2017.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Barings's 13F filing for Q2 2017, filed 14 Aug 2017.